secwatch.observer — SEC 8-K summary
======================================

Issuer:     PRO DEX INC (PDEX)
CIK:        0000788920
Form:       8-K
Filed at:   2024-05-02T23:59:59+00:00
Accession:  0001079973-24-000640
Event type: earnings
Sentiment:  negative
Materiality: 0.60
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Pro-Dex Q3 revenue up 9% to $14.3M; net income falls to $0.19 EPS on investment losses
--------------------------------------------------------------------------------

- Net sales $14.3M (+9% YoY); operating income $2.2M (+7%) driven by medical device revenue.
- Net income $655k ($0.19 diluted EPS) vs $1.6M ($0.45) prior year; decline due to $1.2M unrealized loss on investments.
- Nine-month net sales $38.8M (+10%); operating income $4.8M (+16%).
- Nine-month net income $540k ($0.15 diluted EPS) vs $5.6M ($1.52) due to $3.8M unrealized investment losses.
- CEO Rick Van Kirk says company tracking toward record revenue year; confident in momentum into FY2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/788920/000107997324000640/0001079973-24-000640-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/788920/000107997324000640/pdex_8k.htm
  HTML page:      https://secwatch.observer/filing/0001079973-24-000640

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer